Articles


Care Gap

Prevalence of Dyslipidemia in Statin-Treated Patients in Canada: Results of the DYSlipidemia International Study (DYSIS) [PDF]

Shaun G. Goodman, Anatoly Langer, Natacha R. Bastien, et al

Regional and National Familial Hypercholesterolemia Registries: Present International Application, Importance, and Needs for Canada [PDF]

Ahmad Al-Sarraf, Matt Allard, Michal Martinka, Jiri Frohlich

Guidelines

2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult [PDF] [PDF]

Todd J. Anderson, Jean Grégoire, Robert A. Hegele, et al

2009 Canadian Cardiovascular Society/Canadian Guidelines for the Diagnosis and Treatment of Dyslipidemia and Prevention of Cardiovascular Disease in the Adult [PDF]

Jacques Genest, Ruth McPherson, Jiri Frohlich, et al

Risk Assessment

The Challenges and Benefits of Cardiovascular Risk Assessment in Clinical Practice [PDF]

Steven A. Grover, Ilka Lowensteyn

Ischemic stroke: A cardiovascular Risk Equivalent? Lessons Learned from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial [PDF]

David H. Fitchett, Shaun G. Goodman, Anatoly Langer, MD

Perceptions of Canadian Primary Care Physicians Towards Cardiovascular Risk Assessment and Lipid Management [PDF]

Milan Gupta, Narendra Singh, Michelle Tsigoulis, et al

Therapy

Clinical and Public Health Assessment of Benefits and Risks of Statins in Primary Prevention of Coronary Events: Resolved and Unresolved Issues [PDF]

Yola Moride, McPherson, David B. Miller, Stéphane Rinfret

Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Proceedings of a Canadian Working Group Consensus Conference [PDF]

G. B. John Mancini, Steven Baker, Jean Bergeron, et al

Drugs Targeting High-Density Lipoprotein Cholesterol for Coronary Artery Disease Management [PDF]

Pamela M. Katz, Lawrence A. Leiter

Use of a Treatment Optimization Algorithm Involving Statin-Ezetimibe Combination Aids in Achievement of Guideline-Based Low-Density Lipoprotein Targets in Patients with Dyslipidemia at High Vascular Risk Guideline-Based Undertaking to Improve Dyslipidemia Management in Canada (GUIDANC) [PDF]

Pamela M. Katz, Aurora A. Mendelsohn, Shaun G. Goodman, et al

Adherence

Beyond the Shadow: Getting Past the Veil of Nonadherence in the Management of Atherosclerotic Risk Factors [PDF]

Ross D. Feldman, Tavis S. Campbell

Estimating the Benefits of Patient and Physician Adherence to Cardiovascular Prevention Guidelines: The MyHealthCheckup Survey [PDF]

Steven Grover, Louis Coupal, Mohammed Kouache, et al

Nonadherence to Statin Therapy: Discontinuation after a Single Fill [PDF]

Mark Lemstra, David Blackburn

Proportion and Risk Indicators of Nonadherence to Statin Therapy: A Meta-analysis [PDF]

Mark Lemstra, David Blackburn, Alex Crawley, Ryan Fung

Lifestyle

The Impact of Dietary Changes and Dietary Supplements on Lipid Profile [PDF]

Jingbo Huang, Jiri Frohlich, Andrew P. Ignaszewski